Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Oct;20(41):e2308639.
doi: 10.1002/smll.202308639. Epub 2023 Dec 21.

Nanotechnology Applications in Breast Cancer Immunotherapy

Affiliations
Review

Nanotechnology Applications in Breast Cancer Immunotherapy

Ruijie Wang et al. Small. 2024 Oct.

Abstract

Next-generation cancer treatments are expected not only to target cancer cells but also to simultaneously train immune cells to combat cancer while modulating the immune-suppressive environment of tumors and hosts to ensure a robust and lasting response. Achieving this requires carriers that can codeliver multiple therapeutics to the right cancer and/or immune cells while ensuring patient safety. Nanotechnology holds great potential for addressing these challenges. This article highlights the recent advances in nanoimmunotherapeutic development, with a focus on breast cancer. While immune checkpoint inhibitors (ICIs) have achieved remarkable success and lead to cures in some cancers, their response rate in breast cancer is low. The poor response rate in solid tumors is often associated with the low infiltration of anti-cancer T cells and an immunosuppressive tumor microenvironment (TME). To enhance anti-cancer T-cell responses, nanoparticles are employed to deliver ICIs, bispecific antibodies, cytokines, and agents that induce immunogenic cancer cell death (ICD). Additionally, nanoparticles are used to manipulate various components of the TME, such as immunosuppressive myeloid cells, macrophages, dendritic cells, and fibroblasts to improve T-cell activities. Finally, this article discusses the outlook, challenges, and future directions of nanoimmunotherapeutics.

Keywords: breast cancer; immunosuppression; immunotherapy; nanoparticle; tumor microenvironment.

PubMed Disclaimer

References

    1. Department of Defense Breast Cancer Research Program The Breast Cancer Landscape. https://cdmrp.health.mil/bcrp/pdfs/BreastCancerLandscape2022.pdf (accessed 3/20).
    1. Breast Cancer Research Foundation Breast Cancer Statistics And Resources. https://www.bcrf.org/breast-cancer-statistics-and-resources/ (accessed 7/31).
    1. Liu J; Pandya P; Afshar S, International Journal of Molecular Sciences 2021, 22 (4), 2008. - PMC - PubMed
    1. Caswell-Jin JL; Plevritis SK; Tian L; Cadham CJ; Xu C; Stout NK; Sledge GW; Mandelblatt JS; Kurian AW, JNCI Cancer Spectr 2018, 2 (4), pky062. DOI 10.1093/jncics/pky062. - DOI - PMC - PubMed
    1. Wang J; Xu B, Signal Transduction and Targeted Therapy 2019, 4 (1), 34. DOI 10.1038/s41392-019-0069-2. - DOI - PMC - PubMed

Publication types

LinkOut - more resources